| 000 | 01278 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250512203320.0 | ||
| 264 | 0 | _c19841109 | |
| 008 | 198411s 0 0 eng d | ||
| 022 | _a0012-1797 | ||
| 024 | 7 |
_a10.2337/diab.33.10.937 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSandler, S | |
| 245 | 0 | 0 |
_aNicotinamide does not protect islet B-cell metabolism against alloxan toxicity. _h[electronic resource] |
| 260 |
_bDiabetes _cOct 1984 |
||
| 300 |
_a937-43 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAlloxan _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xmetabolism |
| 650 | 0 | 4 |
_aGlucose _xmetabolism |
| 650 | 0 | 4 |
_aInsulin _xmetabolism |
| 650 | 0 | 4 | _aInsulin Secretion |
| 650 | 0 | 4 |
_aIslets of Langerhans _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNAD _xmetabolism |
| 650 | 0 | 4 |
_aNiacinamide _xpharmacology |
| 650 | 0 | 4 |
_aOxidation-Reduction _xdrug effects |
| 650 | 0 | 4 |
_aOxygen Consumption _xdrug effects |
| 650 | 0 | 4 |
_aProinsulin _xbiosynthesis |
| 700 | 1 | _aWelsh, M | |
| 700 | 1 | _aAndersson, A | |
| 773 | 0 |
_tDiabetes _gvol. 33 _gno. 10 _gp. 937-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2337/diab.33.10.937 _zAvailable from publisher's website |
| 999 |
_c6236987 _d6236987 |
||